Biohaven (BHVN) Partners with SK Biopharmaceuticals Amid Market Challenges
· gurufocus.com
On August 26, 2026, Biohaven Ltd (NYSE: BHVN) announced a global licensing agreement granting SK Biopharmaceuticals exclusive rights to its Kv7 ion channel plat
On August 26, 2026, Biohaven Ltd (NYSE: BHVN) announced a global licensing agreement granting SK Biopharmaceuticals exclusive rights to its Kv7 ion channel plat...